SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination | NEJM
More adverse reactions following bivalent COVID-19 mRNA booster vaccine
Safety of BA.4-5 or BA.1 bivalent mRNA booster vaccines: nationwide cohort study | The BMJ
An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa: Molecular Therapy
Study backs efficacy of half-dosage mRNA booster| สำนักข่าวกรมประชาสัมพันธ์
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar | NEJM
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
RACGP - Four things about mRNA vaccines researchers still want to find out
How to choose a COVID-19 vaccine booster shot
Pfizer (PFE), Moderna (MRNA) Covid Booster Vaccines Greenlighted by CDC Panel - Bloomberg
Bivalent mRNA booster effective, 'essential' for older adults
Study highlights the importance of bivalent mRNA booster vaccination in populations at high risk of severe COVID-19
Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years — United States, March 29, 2022–July 10, 2022 | MMWR
Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2 | Nature Communications
Three mRNA COVID-19 vaccine doses very effective in protecting against emergency department visits and hospitalizations associated with Omicron and Delta variants
Effectiveness of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination against symptomatic Covid-19 infection in Sweden: A nationwide cohort study - The Lancet Regional Health – Europe
Data suggests mRNA booster dose generates stronger antibody response after J&J shot - Axios | Reuters
Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trial - The Lancet
Plug and Play” mRNA technology works fast, updating vaccines in months : Oregon Health News Blog
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022 | MMWR
COVID-19 mRNA booster provides additional protection, most beneficial for older adults
Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study - The Lancet Infectious Diseases
Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine: a prospective and retrospective cohort study - The Lancet Respiratory Medicine
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...
Vaccines | Free Full-Text | mRNA Booster Vaccination Enhances Antibody Responses against SARS-CoV2 Omicron Variant in Individuals Primed with mRNA or Inactivated Virus Vaccines
Durability of omicron-neutralising serum activity after mRNA booster immunisation in older adults - The Lancet Infectious Diseases
Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination | NEJM
Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial - The Lancet Infectious Diseases
